Conversion of high grade lymphoma tumor cell line to intermediate grade with tpa and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis-Reference-Cited by-同舟云学术

Conversion of high grade lymphoma tumor cell line to intermediate grade with tpa and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis

Published:1990-03 Issue:2 Volume:8 Page:81-89
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Al-Katib Ayad,Mohammad Ramzi M.,Mohamed Anwar N.,Pettit George R.,Sensenbrenner Lyle L.

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference26 articles.

1. Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression

2. , (1987). Current methods used in the diagnosis and classification of malignant lymphomas. In: Jr, , , eds. Updates 1, 1–12. J. B. Lippincott Co.

3. Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemia

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant;American Journal of Hematology;2009-08

2. Marine-derived anticancer agents in clinical trials;Expert Opinion on Investigational Drugs;2003-08

3. Bryostatin-1: A Novel PKC Inhibitor in Clinical Development;Cancer Investigation;2003-01

4. BIOSYNTHETIC PRODUCTS FOR ANTICANCER DRUG DESIGN AND TREATMENT: THE BRYOSTATINS;Anticancer Drug Development;2002

5. Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug;Expert Opinion on Investigational Drugs;1999-12